Induced Pluripotent Stem Cells Market Size, Share & Trends Analysis Report By Derived Cell Type (Hepatocytes, Fibroblasts), By Application (Drug Development), By End-use, By Region, And Segment Forecasts, 2024 - 2030

Market Segmentation

• Induced Pluripotent Stem Cells Derived Cell Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Hepatocytes
  • Fibroblasts
  • Keratinocytes
  • Amniotic Cells
  • Others
• Induced Pluripotent Stem Cells Application Outlook (Revenue, USD Million, 2018 - 2030)
  • Drug Development     
  • Tissue Engineering & Regenerative Medicine
    • Neurology
    • Orthopedics
    • Oncology
    • Cardiovascular and Myocardial Infraction
    • Diabetes
    • Others
  • Toxicology Research  
  • Disease Modeling
• Induced Pluripotent Stem Cells End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Others
• Induced Pluripotent Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • North America Induced Pluripotent Stem Cells Market, By Derived Cell Type
      • Hepatocytes
      • Fibroblasts
      • Keratinocytes
      • Amniotic Cells
      • Others
    • North America Induced Pluripotent Stem Cells Market, By Application
      • Drug Development     
      • Tissue Engineering & Regenerative Medicine
        • Neurology
        • Orthopedics
        • Oncology
        • Cardiovascular and Myocardial Infraction
        • Diabetes
        • Others
      • Toxicology Research  
      • Disease Modeling
    • North America Induced Pluripotent Stem Cells Market, By End Use
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Others
    • U.S.
      • U.S. Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • U.S. Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • U.S. Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Canada
      • Canada Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Canada Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Canada Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Mexico
      • Mexico Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Mexico Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Mexico Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
  • Europe
    • Europe Induced Pluripotent Stem Cells Market, By Derived Cell Type
      • Hepatocytes
      • Fibroblasts
      • Keratinocytes
      • Amniotic Cells
      • Others
    • Europe Induced Pluripotent Stem Cells Market, By Application
      • Drug Development     
      • Tissue Engineering & Regenerative Medicine
        • Neurology
        • Orthopedics
        • Oncology
        • Cardiovascular and Myocardial Infraction
        • Diabetes
        • Others
      • Toxicology Research  
      • Disease Modeling
    • Europe Induced Pluripotent Stem Cells Market, By End Use
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Other
    • Germany
      • Germany Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Germany Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Germany Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • UK
      • UK Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • UK Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • UK Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • France
      • France Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • France Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • France Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Italy
      • Italy Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Italy Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Italy Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Spain
      • Spain Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Spain Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Spain Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Denmark
      • Denmark Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Denmark Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Denmark Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Sweden
      • Sweden Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Sweden Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Sweden Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Norway
      • Norway Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Norway Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Norway Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
  • Asia Pacific
    • Asia Pacific Induced Pluripotent Stem Cells Market, By Derived Cell Type
      • Hepatocytes
      • Fibroblasts
      • Keratinocytes
      • Amniotic Cells
      • Others
    • Asia Pacific Induced Pluripotent Stem Cells Market, By Application
      • Drug Development     
      • Tissue Engineering & Regenerative Medicine
        • Neurology
        • Orthopedics
        • Oncology
        • Cardiovascular and Myocardial Infraction
        • Diabetes
        • Others
      • Toxicology Research  
      • Disease Modeling
    • Asia Pacific Induced Pluripotent Stem Cells Market, By End Use
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Other
    • Japan
      • Japan Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Japan Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Japan Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • China
      • China Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • China Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • China Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • India
      • India Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • India Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • India Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • South Korea
      • South Korea Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • South Korea Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • South Korea Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Australia
      • Australia Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Australia Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Australia Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Thailand
      • Thailand Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Thailand Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Thailand Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
  • Latin America
    • Latin America Induced Pluripotent Stem Cells Market, By Derived Cell Type
      • Hepatocytes
      • Fibroblasts
      • Keratinocytes
      • Amniotic Cells
      • Others
    • Latin America Induced Pluripotent Stem Cells Market, By Application
      • Drug Development     
      • Tissue Engineering & Regenerative Medicine
        • Neurology
        • Orthopedics
        • Oncology
        • Cardiovascular and Myocardial Infraction
        • Diabetes
        • Others
      • Toxicology Research  
      • Disease Modeling
    • Latin America Induced Pluripotent Stem Cells Market, By End Use
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Other
    • Brazil
      • Brazil Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Brazil Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Brazil Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Argentina
      • Argentina Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Argentina Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Argentina Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
  • MEA
    • MEA Induced Pluripotent Stem Cells Market, By Derived Cell Type
      • Hepatocytes
      • Fibroblasts
      • Keratinocytes
      • Amniotic Cells
      • Others
    • MEA Induced Pluripotent Stem Cells Market, By Application
      • Drug Development     
      • Tissue Engineering & Regenerative Medicine
        • Neurology
        • Orthopedics
        • Oncology
        • Cardiovascular and Myocardial Infraction
        • Diabetes
        • Others
      • Toxicology Research  
      • Disease Modeling
    • MEA Induced Pluripotent Stem Cells Market, By End Use
      • Academic & Research Institutes
      • Pharmaceutical & Biotechnology Companies
      • Other
    • South Africa
      • South Africa Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • South Africa Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • South Africa Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Saudi Arabia
      • Saudi Arabia Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Saudi Arabia Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Saudi Arabia Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • UAE
      • UAE Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • UAE Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • UAE Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other
    • Kuwait
      • Kuwait Induced Pluripotent Stem Cells Market, By Derived Cell Type
        • Hepatocytes
        • Fibroblasts
        • Keratinocytes
        • Amniotic Cells
        • Others
      • Kuwait Induced Pluripotent Stem Cells Market, By Application
        • Drug Development     
        • Tissue Engineering & Regenerative Medicine
          • Neurology
          • Orthopedics
          • Oncology
          • Cardiovascular and Myocardial Infraction
          • Diabetes
          • Others
        • Toxicology Research  
        • Disease Modeling
      • Kuwait Induced Pluripotent Stem Cells Market, By End Use
        • Academic & Research Institutes
        • Pharmaceutical & Biotechnology Companies
        • Other

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Regional market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Regional market size and forecast for application segments up to 2030
• Company financial performance